Syndicated Research Studies

Market Size & Trends The global oral solid dosage contract manufacturing market size was estimated at USD 36.50 billion in 2023 and is projected to grow at a compound annual growth rate (CAGR) of 5.97% from 2024 to 2030. Growth in the market can be attributed to the increasing advancements in drug delivery technology, including targeted drug delivery & sustained release dosage forms, investments by contract development manufacturing organizations to expand the oral solid dosage development, and demand for novel therapies. In addition, oral pharmaceutical products are likely to be replaced with new technologies anytime shortly. For instance, integrating 3D printing in OSD manufacturing can enable precise control over drug release and help customize dosage forms based on patient needs. This technology allows for the production of complex shapes and formulations, offering flexibility in drug design & manufacturing. Hence, the solid dose pharmaceutical manufacturing expansion...

Oral Solid Dosage Contract Manufacturing Market Growth & Trends The global  oral solid dosage contract manufacturing market  size is expected to reach USD 54.7 billion by 2030 and expand at a CAGR of 5.97% from 2024 to 2030, according to a new report by Grand View Research, Inc. Increasing complexity of new drug molecules, R&D investments by large CMOs & CDMOs and rising demand for novel therapies are key factors driving market growth. Oral solids are widely accepted dosage forms in the pharmaceutical sector since they are cost-effective, simple to manufacture, and patient-friendly. Furthermore, advances in drug delivery technology, such as control release and sustained release formation, are enabling oral solids to achieve even higher levels of bioavailability while lowering drug administration frequency. Thereby, it is anticipated to propel market growth potential. Technological advancements in the development and bulk manufacturing of oral solid dosage forms ...

Oral Solid Dosage Contract Manufacturing Industry Overview The global oral solid dosage contract manufacturing market size was valued at USD 31.9 billion in 2021 and is anticipated to exhibit a compound annual growth rate (CAGR) of 6.0% over the forecast period. An increase in the advancement of drug delivery technology, such as targeted drug delivery and sustained release dosage forms, rising investments by CDMOs to expand the oral solid dosage (OSD) development and increasing demand for novel therapies drive the market growth. Oral dose pharmaceutical products are highly improbable to be replaced with new technologies anytime in the near future. The expansion of solid dose pharmaceutical manufacturing is driven by new solid dose formats and increased efficiency. Gather more insights about the market drivers, restrains and growth of the Global Oral Solid Dosage Contract Manufacturing Market According to an article published in Pharma Manufacturing, tablets would be the preferred ...